Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terzah Horton

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Blood|January 10, 2015
Yin and yang of glucocorticoid receptors in apoptosisTerzah Horton
European Journal of Haematology|March 29, 2013
Children are not large miceTerzah Horton, Stephen P Hunger
Pediatric Blood & Cancer|July 1, 2010
Defining and managing career challenges for mid-career and senior stage pediatric hematologist/oncologistsErnest Frugé, Judith Margolin, Terzah Horton, et al.
Pediatric Blood & Cancer|January 13, 2009
Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosisPatrick A Thompson, Carl E Allen, Terzah Horton, et al.
Pediatric Blood & Cancer|December 21, 2012
Children's Oncology Group's 2013 blueprint for research: Hodgkin lymphomaKara M Kelly, David Hodgson, Burton Appel, et al.
Leukemia & Lymphoma|June 27, 2009
Targeting the Bcl-2 family of proteins in Hodgkin lymphoma: in vitro cytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737Aarthi Jayanthan, Scott C Howard, Tanya Trippett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2004
Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015)Susan M Blaney, Mark Bernstein, Kathleen Neville, et al.
Pediatric Hematology and Oncology|December 1, 2017
Investigating the biology of relapsed acute leukemia: Proceedings of the Therapeutic Advances for Childhood Leukemia & Lymphoma (TACL) Consortium Biology Working GroupDeepa Bhojwani, Michael J Burke, Terzah Horton, et al.
EMBO Reports|July 4, 2019
Extracellular vesicles impose quiescence on residual hematopoietic stem cells in the leukemic nicheSherif Abdelhamed, John T Butler, Ben Doron, et al.
Blood Advances|September 24, 2025
Tumor-specific immune responses and biomarkers in pediatric patients with high-risk Hodgkin lymphomaKeri Toner, Lindsay A Renfro, Hema Dave, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Blood|January 10, 2015
Yin and yang of glucocorticoid receptors in apoptosisTerzah Horton
European Journal of Haematology|March 29, 2013
Children are not large miceTerzah Horton, Stephen P Hunger
Pediatric Blood & Cancer|July 1, 2010
Defining and managing career challenges for mid-career and senior stage pediatric hematologist/oncologistsErnest Frugé, Judith Margolin, Terzah Horton, et al.
Pediatric Blood & Cancer|January 13, 2009
Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosisPatrick A Thompson, Carl E Allen, Terzah Horton, et al.
Pediatric Blood & Cancer|December 21, 2012
Children's Oncology Group's 2013 blueprint for research: Hodgkin lymphomaKara M Kelly, David Hodgson, Burton Appel, et al.
Leukemia & Lymphoma|June 27, 2009
Targeting the Bcl-2 family of proteins in Hodgkin lymphoma: in vitro cytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737Aarthi Jayanthan, Scott C Howard, Tanya Trippett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2004
Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015)Susan M Blaney, Mark Bernstein, Kathleen Neville, et al.
Pediatric Hematology and Oncology|December 1, 2017
Investigating the biology of relapsed acute leukemia: Proceedings of the Therapeutic Advances for Childhood Leukemia & Lymphoma (TACL) Consortium Biology Working GroupDeepa Bhojwani, Michael J Burke, Terzah Horton, et al.
EMBO Reports|July 4, 2019
Extracellular vesicles impose quiescence on residual hematopoietic stem cells in the leukemic nicheSherif Abdelhamed, John T Butler, Ben Doron, et al.
Blood Advances|September 24, 2025
Tumor-specific immune responses and biomarkers in pediatric patients with high-risk Hodgkin lymphomaKeri Toner, Lindsay A Renfro, Hema Dave, et al.
Pageof 2